Advanced Science-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2106109, encodeId=f86d2106109a4, content=12-7submitted，一直到今天都没有变化，是凉凉了嘛？生命科学方向的胃肠单细胞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Dec 14 23:13:02 CST 2022, time=2022-12-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2163811, encodeId=e896216381150, content=大修送回去，要审多久才有消息啊？听说有的要两三个月……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae298747425, createdName=ms10085448, createdTime=Thu Oct 19 20:58:36 CST 2023, time=2023-10-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2177868, encodeId=9ee021e786883, content=偏重的研究方向：医学;医学基础 经验分享：8.10 submit 9.27 一审修回 10.19 一审提交 11.30 accept 12.25 online 感谢审稿人和编辑部的高效率，很顺利的一次投稿。终于有了第一篇代表作。继续努力💪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Thu Dec 28 21:38:54 CST 2023, time=2023-12-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2196930, encodeId=4ba6219693084, content=怎么这么慢，with editory已经9天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93862438625, createdName=123cda67m26(暂无昵称), createdTime=Thu Apr 04 17:33:38 CST 2024, time=2024-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152429, encodeId=0e0e2152429be, content=这个期刊和大CDD比起来怎么样啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/54ae98c06fadb8aed43498766caa8965/ed2d418443fb9273ce63b78308e197be.jpg, createdBy=217c2504826, createdName=124a8810m95(暂无昵称), createdTime=Sat Aug 12 15:19:59 CST 2023, time=2023-08-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2198343, encodeId=06bb219834338, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生物医学;代谢;疾病 经验分享：2024.03.06 Manuscript Submitted 2024.03.12 With Editor 2024.03.12 Under Review 2024.04.11 Reject 提交之后很快送审，两个审稿人，审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表，但仍未改变审稿人的固有印象，其意见也十分不专业，并且严重缺乏本研究的相关背景知识，并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见，其中有两个实验上的补充验证。总的来说体验不算很好，但是审稿速度相对较快，上升类期刊，有生物医学相关稿件可以一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba519116540, createdName=ms9000000188651574, createdTime=Sat Apr 13 23:57:05 CST 2024, time=2024-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2159687, encodeId=b973215968e1a, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学工程 经验分享：3.15submit 3.21under review 4.10返修 4.28再投递 6.6拒稿 23.6.27 申诉后重新submit 23.8.7返回 23.8.24 resubmit 23.9.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f48383052, createdName=ms3000001364437971, createdTime=Mon Sep 25 23:33:16 CST 2023, time=2023-09-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196887, encodeId=692c219688ef9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生命科学 经验分享：投稿一个月不到，送审后被拒，两个审稿人，第二个审稿人就两个小问题，其中一个问题文中已经解决，但对方没认真看文章，最恶心是第一个审稿人，问了一大堆很不专业的问题，而且绝大部分问题在文稿中也早就有研究结果了，他还在那说这里没有证据那里没有证据，看意见的表达风格好像国人，严重怀疑是学生审的，很不专业。很恶心。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10c42124454, createdName=小小子, createdTime=Thu Apr 04 10:04:15 CST 2024, time=2024-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2185809, encodeId=6e472185809b3, content=偏重的研究方向：医学;生物材料;核酸纳米材料 经验分享：有一审后是received reviews completed的友友吗，一般多久会给结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Feb 04 13:20:20 CST 2024, time=2024-02-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2179976, encodeId=b9e721e99765b, content=有没有大佬投稿快3周了还是submitted的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Mon Jan 08 15:30:36 CST 2024, time=2024-01-08, status=1, ipAttribution=广西)]

2022-12-14 ms6000000798925478 来自广东省

12-7submitted，一直到今天都没有变化，是凉凉了嘛？生命科学方向的胃肠单细胞

65 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106109, encodeId=f86d2106109a4, content=12-7submitted，一直到今天都没有变化，是凉凉了嘛？生命科学方向的胃肠单细胞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Dec 14 23:13:02 CST 2022, time=2022-12-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2163811, encodeId=e896216381150, content=大修送回去，要审多久才有消息啊？听说有的要两三个月……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae298747425, createdName=ms10085448, createdTime=Thu Oct 19 20:58:36 CST 2023, time=2023-10-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2177868, encodeId=9ee021e786883, content=偏重的研究方向：医学;医学基础 经验分享：8.10 submit 9.27 一审修回 10.19 一审提交 11.30 accept 12.25 online 感谢审稿人和编辑部的高效率，很顺利的一次投稿。终于有了第一篇代表作。继续努力💪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Thu Dec 28 21:38:54 CST 2023, time=2023-12-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2196930, encodeId=4ba6219693084, content=怎么这么慢，with editory已经9天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93862438625, createdName=123cda67m26(暂无昵称), createdTime=Thu Apr 04 17:33:38 CST 2024, time=2024-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152429, encodeId=0e0e2152429be, content=这个期刊和大CDD比起来怎么样啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/54ae98c06fadb8aed43498766caa8965/ed2d418443fb9273ce63b78308e197be.jpg, createdBy=217c2504826, createdName=124a8810m95(暂无昵称), createdTime=Sat Aug 12 15:19:59 CST 2023, time=2023-08-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2198343, encodeId=06bb219834338, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生物医学;代谢;疾病 经验分享：2024.03.06 Manuscript Submitted 2024.03.12 With Editor 2024.03.12 Under Review 2024.04.11 Reject 提交之后很快送审，两个审稿人，审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表，但仍未改变审稿人的固有印象，其意见也十分不专业，并且严重缺乏本研究的相关背景知识，并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见，其中有两个实验上的补充验证。总的来说体验不算很好，但是审稿速度相对较快，上升类期刊，有生物医学相关稿件可以一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba519116540, createdName=ms9000000188651574, createdTime=Sat Apr 13 23:57:05 CST 2024, time=2024-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2159687, encodeId=b973215968e1a, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学工程 经验分享：3.15submit 3.21under review 4.10返修 4.28再投递 6.6拒稿 23.6.27 申诉后重新submit 23.8.7返回 23.8.24 resubmit 23.9.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f48383052, createdName=ms3000001364437971, createdTime=Mon Sep 25 23:33:16 CST 2023, time=2023-09-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196887, encodeId=692c219688ef9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生命科学 经验分享：投稿一个月不到，送审后被拒，两个审稿人，第二个审稿人就两个小问题，其中一个问题文中已经解决，但对方没认真看文章，最恶心是第一个审稿人，问了一大堆很不专业的问题，而且绝大部分问题在文稿中也早就有研究结果了，他还在那说这里没有证据那里没有证据，看意见的表达风格好像国人，严重怀疑是学生审的，很不专业。很恶心。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10c42124454, createdName=小小子, createdTime=Thu Apr 04 10:04:15 CST 2024, time=2024-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2185809, encodeId=6e472185809b3, content=偏重的研究方向：医学;生物材料;核酸纳米材料 经验分享：有一审后是received reviews completed的友友吗，一般多久会给结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Feb 04 13:20:20 CST 2024, time=2024-02-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2179976, encodeId=b9e721e99765b, content=有没有大佬投稿快3周了还是submitted的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Mon Jan 08 15:30:36 CST 2024, time=2024-01-08, status=1, ipAttribution=广西)]

2023-10-19 ms10085448 来自江苏省

大修送回去，要审多久才有消息啊？听说有的要两三个月……

64 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106109, encodeId=f86d2106109a4, content=12-7submitted，一直到今天都没有变化，是凉凉了嘛？生命科学方向的胃肠单细胞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Dec 14 23:13:02 CST 2022, time=2022-12-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2163811, encodeId=e896216381150, content=大修送回去，要审多久才有消息啊？听说有的要两三个月……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae298747425, createdName=ms10085448, createdTime=Thu Oct 19 20:58:36 CST 2023, time=2023-10-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2177868, encodeId=9ee021e786883, content=偏重的研究方向：医学;医学基础 经验分享：8.10 submit 9.27 一审修回 10.19 一审提交 11.30 accept 12.25 online 感谢审稿人和编辑部的高效率，很顺利的一次投稿。终于有了第一篇代表作。继续努力💪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Thu Dec 28 21:38:54 CST 2023, time=2023-12-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2196930, encodeId=4ba6219693084, content=怎么这么慢，with editory已经9天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93862438625, createdName=123cda67m26(暂无昵称), createdTime=Thu Apr 04 17:33:38 CST 2024, time=2024-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152429, encodeId=0e0e2152429be, content=这个期刊和大CDD比起来怎么样啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/54ae98c06fadb8aed43498766caa8965/ed2d418443fb9273ce63b78308e197be.jpg, createdBy=217c2504826, createdName=124a8810m95(暂无昵称), createdTime=Sat Aug 12 15:19:59 CST 2023, time=2023-08-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2198343, encodeId=06bb219834338, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生物医学;代谢;疾病 经验分享：2024.03.06 Manuscript Submitted 2024.03.12 With Editor 2024.03.12 Under Review 2024.04.11 Reject 提交之后很快送审，两个审稿人，审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表，但仍未改变审稿人的固有印象，其意见也十分不专业，并且严重缺乏本研究的相关背景知识，并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见，其中有两个实验上的补充验证。总的来说体验不算很好，但是审稿速度相对较快，上升类期刊，有生物医学相关稿件可以一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba519116540, createdName=ms9000000188651574, createdTime=Sat Apr 13 23:57:05 CST 2024, time=2024-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2159687, encodeId=b973215968e1a, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学工程 经验分享：3.15submit 3.21under review 4.10返修 4.28再投递 6.6拒稿 23.6.27 申诉后重新submit 23.8.7返回 23.8.24 resubmit 23.9.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f48383052, createdName=ms3000001364437971, createdTime=Mon Sep 25 23:33:16 CST 2023, time=2023-09-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196887, encodeId=692c219688ef9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生命科学 经验分享：投稿一个月不到，送审后被拒，两个审稿人，第二个审稿人就两个小问题，其中一个问题文中已经解决，但对方没认真看文章，最恶心是第一个审稿人，问了一大堆很不专业的问题，而且绝大部分问题在文稿中也早就有研究结果了，他还在那说这里没有证据那里没有证据，看意见的表达风格好像国人，严重怀疑是学生审的，很不专业。很恶心。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10c42124454, createdName=小小子, createdTime=Thu Apr 04 10:04:15 CST 2024, time=2024-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2185809, encodeId=6e472185809b3, content=偏重的研究方向：医学;生物材料;核酸纳米材料 经验分享：有一审后是received reviews completed的友友吗，一般多久会给结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Feb 04 13:20:20 CST 2024, time=2024-02-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2179976, encodeId=b9e721e99765b, content=有没有大佬投稿快3周了还是submitted的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Mon Jan 08 15:30:36 CST 2024, time=2024-01-08, status=1, ipAttribution=广西)]

2023-12-28 ms1000000907051820 来自河南省

偏重的研究方向：医学;医学基础
经验分享：8.10 submit 9.27 一审修回 10.19 一审提交 11.30 accept 12.25 online 感谢审稿人和编辑部的高效率，很顺利的一次投稿。终于有了第一篇代表作。继续努力💪

71 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106109, encodeId=f86d2106109a4, content=12-7submitted，一直到今天都没有变化，是凉凉了嘛？生命科学方向的胃肠单细胞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Dec 14 23:13:02 CST 2022, time=2022-12-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2163811, encodeId=e896216381150, content=大修送回去，要审多久才有消息啊？听说有的要两三个月……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae298747425, createdName=ms10085448, createdTime=Thu Oct 19 20:58:36 CST 2023, time=2023-10-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2177868, encodeId=9ee021e786883, content=偏重的研究方向：医学;医学基础 经验分享：8.10 submit 9.27 一审修回 10.19 一审提交 11.30 accept 12.25 online 感谢审稿人和编辑部的高效率，很顺利的一次投稿。终于有了第一篇代表作。继续努力💪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Thu Dec 28 21:38:54 CST 2023, time=2023-12-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2196930, encodeId=4ba6219693084, content=怎么这么慢，with editory已经9天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93862438625, createdName=123cda67m26(暂无昵称), createdTime=Thu Apr 04 17:33:38 CST 2024, time=2024-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152429, encodeId=0e0e2152429be, content=这个期刊和大CDD比起来怎么样啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/54ae98c06fadb8aed43498766caa8965/ed2d418443fb9273ce63b78308e197be.jpg, createdBy=217c2504826, createdName=124a8810m95(暂无昵称), createdTime=Sat Aug 12 15:19:59 CST 2023, time=2023-08-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2198343, encodeId=06bb219834338, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生物医学;代谢;疾病 经验分享：2024.03.06 Manuscript Submitted 2024.03.12 With Editor 2024.03.12 Under Review 2024.04.11 Reject 提交之后很快送审，两个审稿人，审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表，但仍未改变审稿人的固有印象，其意见也十分不专业，并且严重缺乏本研究的相关背景知识，并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见，其中有两个实验上的补充验证。总的来说体验不算很好，但是审稿速度相对较快，上升类期刊，有生物医学相关稿件可以一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba519116540, createdName=ms9000000188651574, createdTime=Sat Apr 13 23:57:05 CST 2024, time=2024-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2159687, encodeId=b973215968e1a, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学工程 经验分享：3.15submit 3.21under review 4.10返修 4.28再投递 6.6拒稿 23.6.27 申诉后重新submit 23.8.7返回 23.8.24 resubmit 23.9.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f48383052, createdName=ms3000001364437971, createdTime=Mon Sep 25 23:33:16 CST 2023, time=2023-09-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196887, encodeId=692c219688ef9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生命科学 经验分享：投稿一个月不到，送审后被拒，两个审稿人，第二个审稿人就两个小问题，其中一个问题文中已经解决，但对方没认真看文章，最恶心是第一个审稿人，问了一大堆很不专业的问题，而且绝大部分问题在文稿中也早就有研究结果了，他还在那说这里没有证据那里没有证据，看意见的表达风格好像国人，严重怀疑是学生审的，很不专业。很恶心。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10c42124454, createdName=小小子, createdTime=Thu Apr 04 10:04:15 CST 2024, time=2024-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2185809, encodeId=6e472185809b3, content=偏重的研究方向：医学;生物材料;核酸纳米材料 经验分享：有一审后是received reviews completed的友友吗，一般多久会给结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Feb 04 13:20:20 CST 2024, time=2024-02-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2179976, encodeId=b9e721e99765b, content=有没有大佬投稿快3周了还是submitted的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Mon Jan 08 15:30:36 CST 2024, time=2024-01-08, status=1, ipAttribution=广西)]

2024-04-04 123cda67m26(暂无昵称) 来自上海

怎么这么慢，with editory已经9天了

7 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106109, encodeId=f86d2106109a4, content=12-7submitted，一直到今天都没有变化，是凉凉了嘛？生命科学方向的胃肠单细胞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Dec 14 23:13:02 CST 2022, time=2022-12-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2163811, encodeId=e896216381150, content=大修送回去，要审多久才有消息啊？听说有的要两三个月……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae298747425, createdName=ms10085448, createdTime=Thu Oct 19 20:58:36 CST 2023, time=2023-10-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2177868, encodeId=9ee021e786883, content=偏重的研究方向：医学;医学基础 经验分享：8.10 submit 9.27 一审修回 10.19 一审提交 11.30 accept 12.25 online 感谢审稿人和编辑部的高效率，很顺利的一次投稿。终于有了第一篇代表作。继续努力💪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Thu Dec 28 21:38:54 CST 2023, time=2023-12-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2196930, encodeId=4ba6219693084, content=怎么这么慢，with editory已经9天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93862438625, createdName=123cda67m26(暂无昵称), createdTime=Thu Apr 04 17:33:38 CST 2024, time=2024-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152429, encodeId=0e0e2152429be, content=这个期刊和大CDD比起来怎么样啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/54ae98c06fadb8aed43498766caa8965/ed2d418443fb9273ce63b78308e197be.jpg, createdBy=217c2504826, createdName=124a8810m95(暂无昵称), createdTime=Sat Aug 12 15:19:59 CST 2023, time=2023-08-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2198343, encodeId=06bb219834338, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生物医学;代谢;疾病 经验分享：2024.03.06 Manuscript Submitted 2024.03.12 With Editor 2024.03.12 Under Review 2024.04.11 Reject 提交之后很快送审，两个审稿人，审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表，但仍未改变审稿人的固有印象，其意见也十分不专业，并且严重缺乏本研究的相关背景知识，并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见，其中有两个实验上的补充验证。总的来说体验不算很好，但是审稿速度相对较快，上升类期刊，有生物医学相关稿件可以一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba519116540, createdName=ms9000000188651574, createdTime=Sat Apr 13 23:57:05 CST 2024, time=2024-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2159687, encodeId=b973215968e1a, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学工程 经验分享：3.15submit 3.21under review 4.10返修 4.28再投递 6.6拒稿 23.6.27 申诉后重新submit 23.8.7返回 23.8.24 resubmit 23.9.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f48383052, createdName=ms3000001364437971, createdTime=Mon Sep 25 23:33:16 CST 2023, time=2023-09-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196887, encodeId=692c219688ef9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生命科学 经验分享：投稿一个月不到，送审后被拒，两个审稿人，第二个审稿人就两个小问题，其中一个问题文中已经解决，但对方没认真看文章，最恶心是第一个审稿人，问了一大堆很不专业的问题，而且绝大部分问题在文稿中也早就有研究结果了，他还在那说这里没有证据那里没有证据，看意见的表达风格好像国人，严重怀疑是学生审的，很不专业。很恶心。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10c42124454, createdName=小小子, createdTime=Thu Apr 04 10:04:15 CST 2024, time=2024-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2185809, encodeId=6e472185809b3, content=偏重的研究方向：医学;生物材料;核酸纳米材料 经验分享：有一审后是received reviews completed的友友吗，一般多久会给结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Feb 04 13:20:20 CST 2024, time=2024-02-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2179976, encodeId=b9e721e99765b, content=有没有大佬投稿快3周了还是submitted的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Mon Jan 08 15:30:36 CST 2024, time=2024-01-08, status=1, ipAttribution=广西)]

2023-08-12 124a8810m95(暂无昵称) 来自重庆

这个期刊和大CDD比起来怎么样啊？

93 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106109, encodeId=f86d2106109a4, content=12-7submitted，一直到今天都没有变化，是凉凉了嘛？生命科学方向的胃肠单细胞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Dec 14 23:13:02 CST 2022, time=2022-12-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2163811, encodeId=e896216381150, content=大修送回去，要审多久才有消息啊？听说有的要两三个月……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae298747425, createdName=ms10085448, createdTime=Thu Oct 19 20:58:36 CST 2023, time=2023-10-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2177868, encodeId=9ee021e786883, content=偏重的研究方向：医学;医学基础 经验分享：8.10 submit 9.27 一审修回 10.19 一审提交 11.30 accept 12.25 online 感谢审稿人和编辑部的高效率，很顺利的一次投稿。终于有了第一篇代表作。继续努力💪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Thu Dec 28 21:38:54 CST 2023, time=2023-12-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2196930, encodeId=4ba6219693084, content=怎么这么慢，with editory已经9天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93862438625, createdName=123cda67m26(暂无昵称), createdTime=Thu Apr 04 17:33:38 CST 2024, time=2024-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152429, encodeId=0e0e2152429be, content=这个期刊和大CDD比起来怎么样啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/54ae98c06fadb8aed43498766caa8965/ed2d418443fb9273ce63b78308e197be.jpg, createdBy=217c2504826, createdName=124a8810m95(暂无昵称), createdTime=Sat Aug 12 15:19:59 CST 2023, time=2023-08-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2198343, encodeId=06bb219834338, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生物医学;代谢;疾病 经验分享：2024.03.06 Manuscript Submitted 2024.03.12 With Editor 2024.03.12 Under Review 2024.04.11 Reject 提交之后很快送审，两个审稿人，审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表，但仍未改变审稿人的固有印象，其意见也十分不专业，并且严重缺乏本研究的相关背景知识，并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见，其中有两个实验上的补充验证。总的来说体验不算很好，但是审稿速度相对较快，上升类期刊，有生物医学相关稿件可以一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba519116540, createdName=ms9000000188651574, createdTime=Sat Apr 13 23:57:05 CST 2024, time=2024-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2159687, encodeId=b973215968e1a, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学工程 经验分享：3.15submit 3.21under review 4.10返修 4.28再投递 6.6拒稿 23.6.27 申诉后重新submit 23.8.7返回 23.8.24 resubmit 23.9.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f48383052, createdName=ms3000001364437971, createdTime=Mon Sep 25 23:33:16 CST 2023, time=2023-09-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196887, encodeId=692c219688ef9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生命科学 经验分享：投稿一个月不到，送审后被拒，两个审稿人，第二个审稿人就两个小问题，其中一个问题文中已经解决，但对方没认真看文章，最恶心是第一个审稿人，问了一大堆很不专业的问题，而且绝大部分问题在文稿中也早就有研究结果了，他还在那说这里没有证据那里没有证据，看意见的表达风格好像国人，严重怀疑是学生审的，很不专业。很恶心。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10c42124454, createdName=小小子, createdTime=Thu Apr 04 10:04:15 CST 2024, time=2024-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2185809, encodeId=6e472185809b3, content=偏重的研究方向：医学;生物材料;核酸纳米材料 经验分享：有一审后是received reviews completed的友友吗，一般多久会给结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Feb 04 13:20:20 CST 2024, time=2024-02-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2179976, encodeId=b9e721e99765b, content=有没有大佬投稿快3周了还是submitted的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Mon Jan 08 15:30:36 CST 2024, time=2024-01-08, status=1, ipAttribution=广西)]

2024-04-13 ms9000000188651574 来自吉林省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：生物医学;代谢;疾病
经验分享：2024.03.06 Manuscript Submitted
2024.03.12 With Editor
2024.03.12 Under Review
2024.04.11 Reject
提交之后很快送审，两个审稿人，审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表，但仍未改变审稿人的固有印象，其意见也十分不专业，并且严重缺乏本研究的相关背景知识，并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见，其中有两个实验上的补充验证。总的来说体验不算很好，但是审稿速度相对较快，上升类期刊，有生物医学相关稿件可以一试。

4 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106109, encodeId=f86d2106109a4, content=12-7submitted，一直到今天都没有变化，是凉凉了嘛？生命科学方向的胃肠单细胞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Dec 14 23:13:02 CST 2022, time=2022-12-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2163811, encodeId=e896216381150, content=大修送回去，要审多久才有消息啊？听说有的要两三个月……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae298747425, createdName=ms10085448, createdTime=Thu Oct 19 20:58:36 CST 2023, time=2023-10-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2177868, encodeId=9ee021e786883, content=偏重的研究方向：医学;医学基础 经验分享：8.10 submit 9.27 一审修回 10.19 一审提交 11.30 accept 12.25 online 感谢审稿人和编辑部的高效率，很顺利的一次投稿。终于有了第一篇代表作。继续努力💪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Thu Dec 28 21:38:54 CST 2023, time=2023-12-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2196930, encodeId=4ba6219693084, content=怎么这么慢，with editory已经9天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93862438625, createdName=123cda67m26(暂无昵称), createdTime=Thu Apr 04 17:33:38 CST 2024, time=2024-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152429, encodeId=0e0e2152429be, content=这个期刊和大CDD比起来怎么样啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/54ae98c06fadb8aed43498766caa8965/ed2d418443fb9273ce63b78308e197be.jpg, createdBy=217c2504826, createdName=124a8810m95(暂无昵称), createdTime=Sat Aug 12 15:19:59 CST 2023, time=2023-08-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2198343, encodeId=06bb219834338, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生物医学;代谢;疾病 经验分享：2024.03.06 Manuscript Submitted 2024.03.12 With Editor 2024.03.12 Under Review 2024.04.11 Reject 提交之后很快送审，两个审稿人，审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表，但仍未改变审稿人的固有印象，其意见也十分不专业，并且严重缺乏本研究的相关背景知识，并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见，其中有两个实验上的补充验证。总的来说体验不算很好，但是审稿速度相对较快，上升类期刊，有生物医学相关稿件可以一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba519116540, createdName=ms9000000188651574, createdTime=Sat Apr 13 23:57:05 CST 2024, time=2024-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2159687, encodeId=b973215968e1a, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学工程 经验分享：3.15submit 3.21under review 4.10返修 4.28再投递 6.6拒稿 23.6.27 申诉后重新submit 23.8.7返回 23.8.24 resubmit 23.9.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f48383052, createdName=ms3000001364437971, createdTime=Mon Sep 25 23:33:16 CST 2023, time=2023-09-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196887, encodeId=692c219688ef9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生命科学 经验分享：投稿一个月不到，送审后被拒，两个审稿人，第二个审稿人就两个小问题，其中一个问题文中已经解决，但对方没认真看文章，最恶心是第一个审稿人，问了一大堆很不专业的问题，而且绝大部分问题在文稿中也早就有研究结果了，他还在那说这里没有证据那里没有证据，看意见的表达风格好像国人，严重怀疑是学生审的，很不专业。很恶心。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10c42124454, createdName=小小子, createdTime=Thu Apr 04 10:04:15 CST 2024, time=2024-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2185809, encodeId=6e472185809b3, content=偏重的研究方向：医学;生物材料;核酸纳米材料 经验分享：有一审后是received reviews completed的友友吗，一般多久会给结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Feb 04 13:20:20 CST 2024, time=2024-02-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2179976, encodeId=b9e721e99765b, content=有没有大佬投稿快3周了还是submitted的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Mon Jan 08 15:30:36 CST 2024, time=2024-01-08, status=1, ipAttribution=广西)]

2023-09-25 ms3000001364437971 来自北京

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：医学工程
经验分享：3.15submit
3.21under review
4.10返修
4.28再投递
6.6拒稿
23.6.27 申诉后重新submit
23.8.7返回
23.8.24 resubmit
23.9.23 接收

60 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106109, encodeId=f86d2106109a4, content=12-7submitted，一直到今天都没有变化，是凉凉了嘛？生命科学方向的胃肠单细胞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Dec 14 23:13:02 CST 2022, time=2022-12-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2163811, encodeId=e896216381150, content=大修送回去，要审多久才有消息啊？听说有的要两三个月……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae298747425, createdName=ms10085448, createdTime=Thu Oct 19 20:58:36 CST 2023, time=2023-10-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2177868, encodeId=9ee021e786883, content=偏重的研究方向：医学;医学基础 经验分享：8.10 submit 9.27 一审修回 10.19 一审提交 11.30 accept 12.25 online 感谢审稿人和编辑部的高效率，很顺利的一次投稿。终于有了第一篇代表作。继续努力💪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Thu Dec 28 21:38:54 CST 2023, time=2023-12-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2196930, encodeId=4ba6219693084, content=怎么这么慢，with editory已经9天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93862438625, createdName=123cda67m26(暂无昵称), createdTime=Thu Apr 04 17:33:38 CST 2024, time=2024-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152429, encodeId=0e0e2152429be, content=这个期刊和大CDD比起来怎么样啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/54ae98c06fadb8aed43498766caa8965/ed2d418443fb9273ce63b78308e197be.jpg, createdBy=217c2504826, createdName=124a8810m95(暂无昵称), createdTime=Sat Aug 12 15:19:59 CST 2023, time=2023-08-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2198343, encodeId=06bb219834338, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生物医学;代谢;疾病 经验分享：2024.03.06 Manuscript Submitted 2024.03.12 With Editor 2024.03.12 Under Review 2024.04.11 Reject 提交之后很快送审，两个审稿人，审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表，但仍未改变审稿人的固有印象，其意见也十分不专业，并且严重缺乏本研究的相关背景知识，并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见，其中有两个实验上的补充验证。总的来说体验不算很好，但是审稿速度相对较快，上升类期刊，有生物医学相关稿件可以一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba519116540, createdName=ms9000000188651574, createdTime=Sat Apr 13 23:57:05 CST 2024, time=2024-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2159687, encodeId=b973215968e1a, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学工程 经验分享：3.15submit 3.21under review 4.10返修 4.28再投递 6.6拒稿 23.6.27 申诉后重新submit 23.8.7返回 23.8.24 resubmit 23.9.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f48383052, createdName=ms3000001364437971, createdTime=Mon Sep 25 23:33:16 CST 2023, time=2023-09-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196887, encodeId=692c219688ef9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生命科学 经验分享：投稿一个月不到，送审后被拒，两个审稿人，第二个审稿人就两个小问题，其中一个问题文中已经解决，但对方没认真看文章，最恶心是第一个审稿人，问了一大堆很不专业的问题，而且绝大部分问题在文稿中也早就有研究结果了，他还在那说这里没有证据那里没有证据，看意见的表达风格好像国人，严重怀疑是学生审的，很不专业。很恶心。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10c42124454, createdName=小小子, createdTime=Thu Apr 04 10:04:15 CST 2024, time=2024-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2185809, encodeId=6e472185809b3, content=偏重的研究方向：医学;生物材料;核酸纳米材料 经验分享：有一审后是received reviews completed的友友吗，一般多久会给结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Feb 04 13:20:20 CST 2024, time=2024-02-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2179976, encodeId=b9e721e99765b, content=有没有大佬投稿快3周了还是submitted的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Mon Jan 08 15:30:36 CST 2024, time=2024-01-08, status=1, ipAttribution=广西)]

2024-04-04 小小子来自江苏省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：生命科学
经验分享：投稿一个月不到，送审后被拒，两个审稿人，第二个审稿人就两个小问题，其中一个问题文中已经解决，但对方没认真看文章，最恶心是第一个审稿人，问了一大堆很不专业的问题，而且绝大部分问题在文稿中也早就有研究结果了，他还在那说这里没有证据那里没有证据，看意见的表达风格好像国人，严重怀疑是学生审的，很不专业。很恶心。

8 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106109, encodeId=f86d2106109a4, content=12-7submitted，一直到今天都没有变化，是凉凉了嘛？生命科学方向的胃肠单细胞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Dec 14 23:13:02 CST 2022, time=2022-12-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2163811, encodeId=e896216381150, content=大修送回去，要审多久才有消息啊？听说有的要两三个月……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae298747425, createdName=ms10085448, createdTime=Thu Oct 19 20:58:36 CST 2023, time=2023-10-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2177868, encodeId=9ee021e786883, content=偏重的研究方向：医学;医学基础 经验分享：8.10 submit 9.27 一审修回 10.19 一审提交 11.30 accept 12.25 online 感谢审稿人和编辑部的高效率，很顺利的一次投稿。终于有了第一篇代表作。继续努力💪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Thu Dec 28 21:38:54 CST 2023, time=2023-12-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2196930, encodeId=4ba6219693084, content=怎么这么慢，with editory已经9天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93862438625, createdName=123cda67m26(暂无昵称), createdTime=Thu Apr 04 17:33:38 CST 2024, time=2024-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152429, encodeId=0e0e2152429be, content=这个期刊和大CDD比起来怎么样啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/54ae98c06fadb8aed43498766caa8965/ed2d418443fb9273ce63b78308e197be.jpg, createdBy=217c2504826, createdName=124a8810m95(暂无昵称), createdTime=Sat Aug 12 15:19:59 CST 2023, time=2023-08-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2198343, encodeId=06bb219834338, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生物医学;代谢;疾病 经验分享：2024.03.06 Manuscript Submitted 2024.03.12 With Editor 2024.03.12 Under Review 2024.04.11 Reject 提交之后很快送审，两个审稿人，审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表，但仍未改变审稿人的固有印象，其意见也十分不专业，并且严重缺乏本研究的相关背景知识，并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见，其中有两个实验上的补充验证。总的来说体验不算很好，但是审稿速度相对较快，上升类期刊，有生物医学相关稿件可以一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba519116540, createdName=ms9000000188651574, createdTime=Sat Apr 13 23:57:05 CST 2024, time=2024-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2159687, encodeId=b973215968e1a, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学工程 经验分享：3.15submit 3.21under review 4.10返修 4.28再投递 6.6拒稿 23.6.27 申诉后重新submit 23.8.7返回 23.8.24 resubmit 23.9.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f48383052, createdName=ms3000001364437971, createdTime=Mon Sep 25 23:33:16 CST 2023, time=2023-09-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196887, encodeId=692c219688ef9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生命科学 经验分享：投稿一个月不到，送审后被拒，两个审稿人，第二个审稿人就两个小问题，其中一个问题文中已经解决，但对方没认真看文章，最恶心是第一个审稿人，问了一大堆很不专业的问题，而且绝大部分问题在文稿中也早就有研究结果了，他还在那说这里没有证据那里没有证据，看意见的表达风格好像国人，严重怀疑是学生审的，很不专业。很恶心。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10c42124454, createdName=小小子, createdTime=Thu Apr 04 10:04:15 CST 2024, time=2024-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2185809, encodeId=6e472185809b3, content=偏重的研究方向：医学;生物材料;核酸纳米材料 经验分享：有一审后是received reviews completed的友友吗，一般多久会给结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Feb 04 13:20:20 CST 2024, time=2024-02-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2179976, encodeId=b9e721e99765b, content=有没有大佬投稿快3周了还是submitted的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Mon Jan 08 15:30:36 CST 2024, time=2024-01-08, status=1, ipAttribution=广西)]

2024-02-04 12315a97m77暂无昵称来自四川省

偏重的研究方向：医学;生物材料;核酸纳米材料
经验分享：有一审后是received reviews completed的友友吗，一般多久会给结果呀

178 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106109, encodeId=f86d2106109a4, content=12-7submitted，一直到今天都没有变化，是凉凉了嘛？生命科学方向的胃肠单细胞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d39f6490357, createdName=ms6000000798925478, createdTime=Wed Dec 14 23:13:02 CST 2022, time=2022-12-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2163811, encodeId=e896216381150, content=大修送回去，要审多久才有消息啊？听说有的要两三个月……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae298747425, createdName=ms10085448, createdTime=Thu Oct 19 20:58:36 CST 2023, time=2023-10-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2177868, encodeId=9ee021e786883, content=偏重的研究方向：医学;医学基础 经验分享：8.10 submit 9.27 一审修回 10.19 一审提交 11.30 accept 12.25 online 感谢审稿人和编辑部的高效率，很顺利的一次投稿。终于有了第一篇代表作。继续努力💪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Thu Dec 28 21:38:54 CST 2023, time=2023-12-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2196930, encodeId=4ba6219693084, content=怎么这么慢，with editory已经9天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93862438625, createdName=123cda67m26(暂无昵称), createdTime=Thu Apr 04 17:33:38 CST 2024, time=2024-04-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152429, encodeId=0e0e2152429be, content=这个期刊和大CDD比起来怎么样啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/54ae98c06fadb8aed43498766caa8965/ed2d418443fb9273ce63b78308e197be.jpg, createdBy=217c2504826, createdName=124a8810m95(暂无昵称), createdTime=Sat Aug 12 15:19:59 CST 2023, time=2023-08-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2198343, encodeId=06bb219834338, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生物医学;代谢;疾病 经验分享：2024.03.06 Manuscript Submitted 2024.03.12 With Editor 2024.03.12 Under Review 2024.04.11 Reject 提交之后很快送审，两个审稿人，审稿人1不认可工作内容。文章在讨论中明确提出有类似工作已经发表，但仍未改变审稿人的固有印象，其意见也十分不专业，并且严重缺乏本研究的相关背景知识，并未提出实质性修改意见但建议reject。审稿人2总共提供了7点意见，其中有两个实验上的补充验证。总的来说体验不算很好，但是审稿速度相对较快，上升类期刊，有生物医学相关稿件可以一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba519116540, createdName=ms9000000188651574, createdTime=Sat Apr 13 23:57:05 CST 2024, time=2024-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2159687, encodeId=b973215968e1a, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：医学工程 经验分享：3.15submit 3.21under review 4.10返修 4.28再投递 6.6拒稿 23.6.27 申诉后重新submit 23.8.7返回 23.8.24 resubmit 23.9.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f48383052, createdName=ms3000001364437971, createdTime=Mon Sep 25 23:33:16 CST 2023, time=2023-09-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196887, encodeId=692c219688ef9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生命科学 经验分享：投稿一个月不到，送审后被拒，两个审稿人，第二个审稿人就两个小问题，其中一个问题文中已经解决，但对方没认真看文章，最恶心是第一个审稿人，问了一大堆很不专业的问题，而且绝大部分问题在文稿中也早就有研究结果了，他还在那说这里没有证据那里没有证据，看意见的表达风格好像国人，严重怀疑是学生审的，很不专业。很恶心。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10c42124454, createdName=小小子, createdTime=Thu Apr 04 10:04:15 CST 2024, time=2024-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2185809, encodeId=6e472185809b3, content=偏重的研究方向：医学;生物材料;核酸纳米材料 经验分享：有一审后是received reviews completed的友友吗，一般多久会给结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Feb 04 13:20:20 CST 2024, time=2024-02-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2179976, encodeId=b9e721e99765b, content=有没有大佬投稿快3周了还是submitted的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Mon Jan 08 15:30:36 CST 2024, time=2024-01-08, status=1, ipAttribution=广西)]

2024-01-08 xiaozou_up20 来自广西

有没有大佬投稿快3周了还是submitted的

39 10

展开10条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务